NZ736516A - Methods of tissue repair and regeneration - Google Patents

Methods of tissue repair and regeneration

Info

Publication number
NZ736516A
NZ736516A NZ736516A NZ73651616A NZ736516A NZ 736516 A NZ736516 A NZ 736516A NZ 736516 A NZ736516 A NZ 736516A NZ 73651616 A NZ73651616 A NZ 73651616A NZ 736516 A NZ736516 A NZ 736516A
Authority
NZ
New Zealand
Prior art keywords
site
injury
induces
regeneration
tissue
Prior art date
Application number
NZ736516A
Other languages
English (en)
Inventor
Yujian James Kang
Original Assignee
Innolife Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innolife Co Ltd filed Critical Innolife Co Ltd
Publication of NZ736516A publication Critical patent/NZ736516A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Prostheses (AREA)
NZ736516A 2015-04-22 2016-04-08 Methods of tissue repair and regeneration NZ736516A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2015/077136 WO2016168993A1 (en) 2015-04-22 2015-04-22 Methods of tissue repair and regeneration
PCT/CN2016/078873 WO2016169416A1 (en) 2015-04-22 2016-04-08 Methods of tissue repair and regeneration

Publications (1)

Publication Number Publication Date
NZ736516A true NZ736516A (en) 2019-04-26

Family

ID=57142823

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ736516A NZ736516A (en) 2015-04-22 2016-04-08 Methods of tissue repair and regeneration

Country Status (25)

Country Link
US (1) US11077138B2 (enExample)
EP (1) EP3285782B1 (enExample)
JP (2) JP6895388B2 (enExample)
KR (2) KR20170137919A (enExample)
CN (1) CN107921062B (enExample)
AU (1) AU2016250971B2 (enExample)
BR (1) BR112017022355A2 (enExample)
CA (1) CA2982840C (enExample)
CL (1) CL2017002600A1 (enExample)
CO (1) CO2017010382A2 (enExample)
DK (1) DK3285782T3 (enExample)
EA (1) EA038598B1 (enExample)
EC (1) ECSP17068922A (enExample)
ES (1) ES2898655T3 (enExample)
HK (1) HK1251181A1 (enExample)
HU (1) HUE056650T2 (enExample)
IL (1) IL255116B (enExample)
MX (1) MX2017013122A (enExample)
MY (1) MY189322A (enExample)
NZ (1) NZ736516A (enExample)
PE (1) PE20180240A1 (enExample)
SG (1) SG11201708431QA (enExample)
TW (1) TWI702956B (enExample)
UA (1) UA124332C2 (enExample)
WO (2) WO2016168993A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016168993A1 (en) 2015-04-22 2016-10-27 Innolife Co., Ltd. Methods of tissue repair and regeneration
WO2017049529A1 (en) 2015-09-24 2017-03-30 Innolife Co., Ltd. A pharmaceutical composition comprising a copper chelating tetramine and the use thereof
CN106754662B (zh) * 2016-11-21 2019-11-12 中国人民解放军军事医学科学院基础医学研究所 心肌细胞的制备方法
TWI615127B (zh) * 2017-01-17 2018-02-21 正崴精密工業股份有限公司 計算血壓的方法及其裝置
WO2018217710A1 (en) * 2017-05-22 2018-11-29 The Regents Of The University Of California Micro/nanobubble solutions for tissue preservation and generation thereof
TWI635469B (zh) * 2017-08-29 2018-09-11 國立臺北商業大學 用於反應力訓練的電腦程式產品
TWI634528B (zh) * 2017-08-29 2018-09-01 國立臺北商業大學 用於評估認知能力的電腦程式產品
KR102121417B1 (ko) * 2018-10-08 2020-06-10 가천대학교 산학협력단 Stat3 활성화제를 이용한 골격근세포 분화 유도용 조성물 및 이를 이용한 골격근세포 분화 유도 방법
US12285182B2 (en) 2018-10-10 2025-04-29 Innova Vascular, Inc. Devices and methods for removing an embolus
CN109513037B (zh) * 2018-11-14 2021-09-17 华中科技大学同济医学院附属协和医院 一种负载介孔生物玻璃的小肠粘膜下层创面敷料
US20220176011A1 (en) * 2019-02-18 2022-06-09 Lankenau Institute For Medical Research Scar reducing wound closure materials
CN110288581B (zh) * 2019-06-26 2022-11-04 电子科技大学 一种基于保持形状凸性水平集模型的分割方法
US20220347188A1 (en) * 2019-06-27 2022-11-03 Friedrich Miescher Insitute For Biomedical Research Promoting tissue regeneration
CN111297895A (zh) * 2020-02-20 2020-06-19 成都因诺生物医药科技有限公司 用于治疗动脉粥样硬化的组合物的制药用途
EP4267201A4 (en) * 2020-12-22 2024-11-20 Fluidx Medical Technology, Inc. In situsolidifying injectable compositions with transient contrast agents and methods of making and using thereof
US20240366183A1 (en) * 2021-09-08 2024-11-07 The Board Of Trustees Of The University Of Illinois Real-time super-resolution ultrasound microvessel imaging and velocimetry
CN114010163B (zh) * 2021-12-02 2023-12-19 中国中医科学院医学实验中心 基于光学成像的表皮细胞迁移定位系统及方法
CN114469897B (zh) * 2022-01-12 2023-02-28 上海市胸科医院 靶向治疗心肌梗死的锂皂石复合递送材料及其制备与应用
CN115177786A (zh) * 2022-07-14 2022-10-14 山东大学 一种原位负载蒙脱土/纳米羟基磷灰石的壳聚糖复合支架材料及其制备方法
WO2024237752A1 (ko) * 2023-05-12 2024-11-21 국립해양생물자원관 다중구리 산화효소 펩타이드 및 이로부터 유래된 펩타이드를 포함하는 상처 치유 또는 피부 재생용 조성물
CN117547554B (zh) * 2024-01-12 2024-05-14 山东康根源生物集团有限公司 一种间充质干细胞修复制剂及其制备方法
CN118879625A (zh) * 2024-07-24 2024-11-01 南方医科大学珠江医院 一种硫化铜工程化干细胞外泌体的制备方法及其应用
TWI924567B (zh) * 2025-07-31 2026-05-01 明志科技大學 結合α-酮戊二酸之聚離胺酸奈米羥基磷灰石及其用途

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
JPH03297475A (ja) * 1990-04-16 1991-12-27 Ken Ishihara 共振音波により薬物の放出を制御する方法
US5558082A (en) 1995-01-09 1996-09-24 Spencer; Robert F. Method of intubating a patient and introducer for use with such method
ATE248511T1 (de) 1996-03-12 2003-09-15 Univ Nebraska Zusammensetzung zur zielortspezifischen verabreichung eines medikamentes und verfahren zur anwendung
US6896659B2 (en) 1998-02-06 2005-05-24 Point Biomedical Corporation Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
GB9826658D0 (en) 1998-12-03 1999-01-27 Univ London Tissue repair
SK16182003A3 (sk) * 2001-06-12 2004-05-04 Cellomeda Oy Porézny hubovitý celulózový materiál na ošetrenie zranení
US20060100278A1 (en) * 2002-08-20 2006-05-11 Cooper Garth J S Dosage forms and related therapies
CN1688301A (zh) 2002-08-20 2005-10-26 普罗特米克斯公司 药物剂型及相关的治疗用途
NZ555072A (en) 2004-11-07 2010-09-30 Cupron Corp Copper containing materials for treating wounds, burns and other skin conditions
US20070048387A1 (en) * 2005-09-01 2007-03-01 Edwards Jeffrey D Tissue disruption treatment and composition for use thereof
HUE036745T2 (hu) 2006-11-03 2018-07-30 Multiple Sclerosis Res Center Of New York Csontvelõ eredetû mesenchimális õssejtek, mint a neurális progenitor sejtek forrásai
US8287896B2 (en) * 2010-01-06 2012-10-16 The Curators Of The University Of Missouri Scaffolds with trace element for tissue regeneration in mammals
EP2453844B1 (en) * 2009-07-16 2020-09-02 The Curators Of The University Of Missouri Scaffolds with trace element for tissue regeneration in mammals
US8481066B2 (en) 2009-07-16 2013-07-09 The Curators Of The University Of Missouri Scaffold for tissue regeneration in mammals
CN101926821B (zh) * 2010-07-12 2012-01-25 四川大学华西医院 一种靶向释放微量元素的药物组合物及制备方法和应用
CN102302507B (zh) * 2010-07-12 2014-02-05 四川大学华西医院 定向控释微量元素的药物组合物及制备方法和应用
CN103502218B (zh) 2011-03-04 2016-08-17 生命科技公司 用于缀合生物分子的化合物和方法
JP5598864B2 (ja) 2011-12-05 2014-10-01 北海道公立大学法人 札幌医科大学 細胞増殖方法ならびに組織の修復および再生のための医薬
CN103467578B (zh) * 2012-06-08 2015-07-08 四川大学华西医院 一种短肽、载铜纳米生物材料及在制备治疗脑梗死的药物中的应用
WO2014027474A1 (ja) * 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞
KR101628586B1 (ko) 2012-08-28 2016-06-08 (주)오리지날 바이오메디칼스 킬레이트 복합 교질입자로 구성된 의약 조성물의 제어방출방법
WO2014132262A1 (en) 2013-02-28 2014-09-04 Ramot At Tel-Aviv University Ltd. Peptide-based hydrogel particles and uses thereof
CN105753719B (zh) 2014-12-17 2019-06-21 四川科瑞德凯华制药有限公司 一种盐酸曲恩汀化合物
WO2016168993A1 (en) 2015-04-22 2016-10-27 Innolife Co., Ltd. Methods of tissue repair and regeneration
WO2017049529A1 (en) 2015-09-24 2017-03-30 Innolife Co., Ltd. A pharmaceutical composition comprising a copper chelating tetramine and the use thereof

Also Published As

Publication number Publication date
DK3285782T3 (da) 2021-12-06
SG11201708431QA (en) 2017-11-29
MY189322A (en) 2022-02-04
CN107921062B (zh) 2021-03-02
MX2017013122A (es) 2018-06-18
HUE056650T2 (hu) 2022-02-28
IL255116A0 (en) 2017-12-31
BR112017022355A2 (pt) 2018-07-10
IL255116B (en) 2020-10-29
WO2016168993A1 (en) 2016-10-27
EP3285782A4 (en) 2018-12-12
CL2017002600A1 (es) 2018-03-23
JP2018520090A (ja) 2018-07-26
KR102347010B1 (ko) 2022-01-04
JP2020143158A (ja) 2020-09-10
US20180099008A1 (en) 2018-04-12
US11077138B2 (en) 2021-08-03
PE20180240A1 (es) 2018-01-31
CN107921062A (zh) 2018-04-17
JP6895388B2 (ja) 2021-06-30
ECSP17068922A (es) 2018-02-28
HK1247825A1 (zh) 2018-10-05
AU2016250971A1 (en) 2017-11-02
EA201792307A1 (ru) 2018-06-29
CO2017010382A2 (es) 2018-01-05
AU2016250971B2 (en) 2021-04-29
EA038598B1 (ru) 2021-09-21
EP3285782B1 (en) 2021-09-08
ES2898655T3 (es) 2022-03-08
TWI702956B (zh) 2020-09-01
EP3285782A1 (en) 2018-02-28
KR20200000458A (ko) 2020-01-02
WO2016169416A1 (en) 2016-10-27
HK1251181A1 (zh) 2019-01-25
CA2982840C (en) 2022-10-25
TW201642876A (zh) 2016-12-16
KR20170137919A (ko) 2017-12-13
CA2982840A1 (en) 2016-10-27
UA124332C2 (uk) 2021-09-01

Similar Documents

Publication Publication Date Title
MX2017013122A (es) Metodos de reparacion y regeneracion tisular.
CY1120729T1 (el) Πεπτιδια και συνθεσεις για τη θεραπεια τραυματισμου των αρθρωσεων
NZ722020A (en) Bifunctional cytotoxic agents
NZ730563A (en) Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same
CL2018003438A1 (es) Anticuerpos a la alfa-sinucleína y usos de los mismos.
MX2017003246A (es) Macropinocitosis de anticuerpos anti-cd46 humanos y agentes terapeuticos dirigidos contra el cancer.
BR112018003985A2 (pt) macrociclos peptidomiméticos e usos dos mesmos
IL272593A (en) Methods of treatment of osteoarthritis with transdermal cannabidiol gel
MX2018005315A (es) Composiciones y metodos para el tratamiento del cancer.
ECSP17018120A (es) Triazolopirazinonas como inhibidores de pde1
MX2016004822A (es) Modelos de cancer y metodos asociados.
MX376324B (es) Proteinas de union a desmogelina 2 (dsg2) y usos de los mismos.
BR112017027954A2 (pt) métodos de tratamento de tumores de célula epitelioide
CL2017002719A1 (es) Imidazopirazinonas como inhibidores de pde1
EP3581182A4 (en) DRUG COMBINATION FOR THE TREATMENT OF PROSTATE CANCER, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT
MX359201B (es) Polipeptidos que se unen al complemento humano 5 (c5).
BR112017000301A2 (pt) tratamento de leucemia com inibidores de histona desacetilase
BR112016024827A2 (pt) método para fabricar pó de metal
MX2017000141A (es) Nanoparticulas terapeuticas dirigidas y metodos para elaborar y utilizar las mismas.
PH12018502303A1 (en) Compositions and methods for bioengineered tissues
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
UA117933C2 (uk) Поліпептид, здатний зв'язувати с5-компонент комплементу людини
BR112017025447A2 (pt) angiogêse utilizando células-tronco da placenta estimuladas
CO2019003865A2 (es) Proteína terapéutica
BR112015024877A2 (pt) vacinas que compreendem polipeptídeos de leishmania para o tratamento e diagnóstico de leishmaniose

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 APR 2021 BY CPA GLOBAL

Effective date: 20200220

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 APR 2022 BY CPA GLOBAL

Effective date: 20210225

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 APR 2023 BY CPA GLOBAL

Effective date: 20220224

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 APR 2024 BY CPA GLOBAL

Effective date: 20230223

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 APR 2025 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS

Effective date: 20240223

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 APR 2026 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS

Effective date: 20250227

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 APR 2027 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS

Effective date: 20260219